Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting
{{output}}
Objectives: Although high-throughput sequencing is revolutionising medicine, data on the actual cost of whole exome sequencing (WES) applications are needed. We aimed at assessing the cost of WES at a French cancer institute in 2... ...
